Tech Company Financing Transactions
Harkness Pharmaceuticals Funding Round
Harkness Pharmaceuticals closed a $1 million venture capital round on 3/31/2007. Investors included Sanderling Ventures.
Transaction Overview
Company Name
Announced On
3/31/2007
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4401 Eastgate Mall
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Email Address
Overview
Harkness Pharmaceuticals, Inc., is a privately-held development stage biopharmaceutical company focused on developing novel therapies for obesity. The Company has initiated detailed human clinical trials for its first product, an oral formulation of the peptide enterostatin for the treatment of obesity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Wollaeger
Chief Scientific Officer
Byron Rubin
Founder
Edward Dennis
VP - Bus. Development
Peter McWilliams
Browse more venture capital transactions:
Prev: 3/31/2007: Innovative Spinal Technologies venture capital transaction
Next: 3/31/2007: Intradigm venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs